Skip to main content
Download PDF

Effect of umbilical cord blood-mononuclear cells on knee osteoarthritis in rabbits

Journal of Orthopaedic Surgery and Research volume 19, Article number: 323 (2024) Cite this article

Abstract

Background

To investigate the effect and underlying mechanism of umbilical cord blood-mononuclear cells (UCB-MNCs) in treating knee osteoarthritis (KOA) in rabbits.

Methods

A rabbit KOA model was prepared by anterior cruciate ligament transection (ACLT). Fifty New Zealand white rabbits were randomly divided into the control group, model group, sodium hyaluronate (SH) group, platelet-rich plasma (PRP) group and UCB-MNC group. Knee injections were performed once a week for five consecutive weeks. The gross view of the knee joint, morphology of knee cartilage and structural changes in the knee joint were observed on CT scans, and graded by the Lequesne MG behavioral score and the Mankin score. TNF-α and IL-1β levels in the synovial fluid of the knee were measured by the enzyme-linked immunosorbent assay (ELISA). Expression levels of MMP-13 and COL-II in the knee cartilage were detected by Western blotting and qRT-PCR.

Results

The Lequesne MG behavioral score and the Mankin score were significantly higher in the model group than those in the control group (P < 0.05). Rabbits in the SH, PRP and UCB-MNC groups had sequentially lower scores than those in the model group. Imaging features of KOA were more pronounced in the model group than in the remaining groups. CB-MNC significantly relieved KOA, compared to SH and PRP. Significantly higher levels of TNF-α and IL-1β in the synovial fluid of the knee, and up-regulated MMP-13 and down-regulated COL-II in the knee cartilage were detected in the model group than in the control group. These changes were significantly reversed by the treatment with SH, PRP and UCB-MNCs, especially UCB-MNCs.

Conclusion

Injections of UCB-MNCs into knees protect the articular cartilage and hinder the progression of KOA in rabbits by improving the local microenvironment at knee joints.

Introduction

Knee osteoarthritis (KOA) is a kind of degenerative disease characterized by progressive breakdown of articular cartilage, local pain, and limited range of motion [1, 2]. Oral medications (e.g., nonsteroidal anti-inflammatory drugs, opioids, and symptomatic slow-acting drugs), injections of sodium hyaluronate (SH) or platelet-rich plasma (PRP) into knees, and surgical procedures are currently the major therapeutic strategies for KOA. Surgery is usually the last resort for severe KOA [3], posing a great financial burden on affected patients [4]. Cheap, effective, and safe treatment approaches of KOA are urgently needed to promote cartilage regeneration and inhibit local inflammation [5].

Stem cells have been extensively applied for spinal cord damage and neonatal hypoxic-ischemic encephalopathy, owing to their regenerative and anti-inflammatory properties [6]. Human umbilical cord blood (hUCB)-stem cells present high expansion potential, low immunogenicity and can be simply isolated and cultured [7,8,9]. Human umbilical cord blood-mononuclear cells (hUCB-MNCs) consist of hemopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs), lymphocytes and monocytes. They demonstrate strong tissue-repairing and anti-inflammatory functions [10]. Preclinical evidences have validated the high efficacy of MSC injections in accelerating cartilage repair in small animals with OA [11, 12]. hUCB-MNCs have also been reported to regulate immune responses in inflammatory-related diseases, such as renal tubulointerstitial fibrosis [13] and lipopolysaccharide-induced acute kidney injury [14]. However, hUCB-MNC has never been employed in the treatment of KOA. Given the advantages of cheapness, low immunogenicity and nothingness with ethical issues, it is postulated that hUCB-MNC may be a promising treatment for KOA. Therefore, we conducted the present experiment to explore the effect of hUCB-MNC on KOA in rabbits.

Materials and methods

A rabbit model of KOA

Fifty male New Zealand white rabbits aged 6 months and weighing 2.5–3.0 kg (Xilingjiao Breeding Centre, Jinan, China; license number: SCXK (Lu) 20,180,010) were habituated for one week. They were randomly divided into the control group, model group, SH group, PRP group and hUCB-MNC group, with 10 rabbits per group. The rabbit KOA model in the latter four groups was prepared by the anterior cruciate ligament transection (ACLT) as previously reported [15]. In brief, a median incision 4 cm in length was made on the knee joint to expose the joint cavity via a medial parapatellar approach. External rotation of the patella, transection of the anterior cruciate ligament and excision of the medial meniscus were then performed. A daily intramuscular injection of 8.0 × 105 units of penicillin was given for three days to prevent postoperative infections. One week after surgery, rabbits were assisted to make early activities for half an hour once and twice a day. Six weeks after surgery, the KOA rabbit model was established [16] (Fig. 1). All animal experiments were conducted under the Guidelines for Humanitarian Treatment of Laboratory Animals issued by the Ministry of Science and Technology of China in 2006, and approved by the Animal Care and Use Committee of Binzhou Medical College.

Fig. 1
figure 1

Diagram of creating the KOA rabbit model. (A) Exposure of the knee joint. (B) Transection of the anterior cruciate ligament and excision of the medial meniscus. (C) Visible swelling of the knee (arrow point). (D) A micro-CT scan visualizing the formation of a bone capsule

Full size image

Animal interventions

hUCB-MNCs and PRP were provided by the Cord Blood Hematopoietic Stem Cell Bank of Shandong Province. Briefly, hUCB-MNCs (0.5 × 108/4 ml) cryopreserved in liquid nitrogen were resuscitated in a water bath at 37℃. Cells suspended in the washing solution (normal saline + 20% human albumin) in a 3:1 ratio were centrifuged at 1200 r for 10 min. The precipitant was re-suspended in the washing solution and centrifuged again. Finally, a single-cell suspension of hUCB-MNCs (4 × 106 cells/0.3 ml) was prepared. PRP (2.5 × 109/4 ml) was centrifuged at 1200 r for 10 min and prepared at a platelet concentration of 4.5 × 108 cells/0.3 ml. Then, 0.3 ml of normal saline, 0.3 ml of sodium hyaluronate (20 mg/2 ml), 0.3 ml of PRP and 0.3 ml of cell suspension containing 4 × 106 hUCB-MNCs were injected into knees. from the 7th week after surgery once a week for five weeks in the model group, SH group, PRP group and hUCB-MNC group, respectively. Rabbits in the control group were treated with blank control.

Behavioral assessments

Behavioral assessments were carried out by grading the Lequesne MG behavioral score as previously reported [17]. On the 7th day after the last intervention, it was administered in a double-blind fashion by two investigators who were not involved in the experiment but familiar with the behavioral assessment.

Micro-CT

High-resolution micro-CT scans (25 μm, 80 kV) of the right knee joint of the rabbit were obtained using a small animal CT system (Hiscan).

Pathological staining

After five weeks of injections, rabbits were sacrificed to collect the cartilage specimens of femoral condyles on the modeling side, which were fixed in 10% paraformaldehyde for 48 h, decalcified with 10% EDTA for 8 wk, dehydrated, and paraffin-embedded into 5-μm -thick sections. After permeabilization in xylene and deparaffinization, cartilage specimens were stained with hematoxylin and eosin (H&E) staining solution and Safranin O/ Fast green stain (Solarbio, Beijing, China). The morphology of the cartilage tissues in three randomly selected fields per sample was observed under an inverted microscope, and the damage to the cartilages was quantified using the Mankin scoring system as follows [18].

ELISA

After five weeks of drug intervention, the animals were sacrificed by air occlusion. The hair around the knee joint was shaved, and the skin anterior to the knee joint was cut along the midline, meanwhile preserving the joint capsule. Every 2 ml of sterile saline was aspirated with a 5 ml syringe and slowly injected into the joint cavity along the articular surface of the patella. Joint fluid was extracted from sites as far as possible, and the supernatant was subsequently retained by centrifugation and stored at -80℃ for further analysis. The concentrations of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in joint fluid were detected by rabbit specific ELISA kit.

qRT-PCR

Total RNAs in the articular cartilages were extracted using the TRIzol method (Takara, Beijing, China), and the concentration and purity of RNAs were determined using a spectrophotometer (Thermo Scientific, MA, U.S.A.). The extracted RNAs were reversely transcribed into cDNAs. Subsequently, amplification reactions of qRT-PCR using the cDNA as a template were performed on the fluorescence quantitative PCR system (Applied Biosystems, MA, U.S.A.). Relative levels were normalized to that of GAPDH using the 2−ΔΔCT. Sequences of primers (Accurate Biotechnology, Changsha, China) used in qRT-PCR are listed in Table 1.

Table 1 Sequences of primers used in qRT-PCR
Full size table

Western blotting

Total proteins were extracted from knee cartilage tissues using the RIPA lysate (Meilunbio, Dalian, China). Protein samples were loaded onto SDS-PAGE gel (Beyotime, Shanghai, China) for electrophoresis and transferred onto a PVDF membrane. After immersing in 5% skim milk for 2 h, membranes in interested sizes were incubated with the primary antibodies of anti-β-actin (1:1000, Sc-47,778, Santa Cruz Biotechnology, TX, U.S.A.), anti-MMP-13 (1:1000, 18165-1-AP, Proteintech, CA, U.S.A.), anti-Col-II (1:1000, 28459-1-AP, Proteintech), anti-AKT1/2/3 (1:1000, bs- 6951R, Bioss, MA, U.S.A.), anti-phospho-AKT (1:1000, bs0876R, Bioss), anti-PI3KCA (1:1000, 2067R, Bioss) and anti-PI3K p110 beta (1:1000, bs-10657R, Bioss) overnight at 4 °C. On the other day, they were incubated with HRP-linked anti-rabbit IgG (1:5000, #7074, Cell Signaling Technology, MA, U.S.A.) and HRP-linked anti-mouse IgG (1:5000, #7076, Cell Signaling Technology) at room temperature for 1 h. Images were visualized using an enhanced chemiluminescence kit (Meilunbio) and grey values were analyzed using ImageJ software.

Statistical analysis

Statistical analysis was performed using SPSS statistical software. Measurement data were expressed as mean ± standard deviation (\(\stackrel{-}{\varvec{x}}\)±s), and differences among three and more groups were analyzed by one-way ANOVA. A significant difference was determined by a p value of less than 0.05.

Results

Behavioral changes in KOA rabbits

Behavioral changes in rabbits were assessed using the Lequesne MG behavioral scoring system. Rabbits in the control group were graded with 0 points, indicating no behavioral changes. The Lequesne MG behavioral scores in the model group, SH group, PRP group and UCB-MNC group were 8.00 ± 0.58 points, 6.00 ± 1.00 points, 3.80 ± 0.69 points and 2.50 ± 0.50 points, respectively. It is suggested that injections of CB-MNCs into knees significantly improve animal behavior, and this protective efficacy was superior to those of SH and PRP (Fig. 2).

Fig. 2
figure 2

Lequesne MG behavioral scores n = 6. #P < 0.05 and ##P < 0.01 vs. UCB-MNC group; *P < 0.05 and **P < 0.01 vs. model group

Full size image

Gross morphology of knee cartilages

The gross view of the cartilage of femoral condyle was observed. Rabbits in the control group presented bright and translucent cartilages, as well as smooth surfaces of knees. Significant changes in the knee joint were observed in the model group, including rough and uneven cartilages and irregular osteophytes formed on the knee edge. Similar morphological manifestations of rough and uneven cartilages and formation of osteophytes were found in the SH group. In the PRP group, superficial cracks were occasionally observed on the surface of cartilages. KOA-induced morphological changes were significantly alleviated in the UCB-MNC group, manifesting as sporadic rough cartilages and regular edges of knees (Fig. 3).

Fig. 3
figure 3

Gross views of the cartilages of femoral condyles

Full size image

Micro-CT scanning of knees

In the control group, micro-CT scans showed smooth articular surfaces on the femoral condyles and tibial plateaus of knee joints, with normal joint spaces but no bone hyperplasia or osteoporosis. Significant narrowing of joint space and formation of osteophytes were observed in the model group and SH group. Injections of PRP and UCB-MNCs into knees effectively widened joint space and reduced osteophytes. Overall, micro-CT scanning revealed a protective effect of injections of PRP and UCB-MNCs against KOA-induced articular injuries (Fig. 4).

Fig. 4
figure 4

Coronal and cross-sectional micro-CT scans of knees in control group, model group, SH group, PRP group and UCB-MNC group. n = 3. Pathological changes were marked by arrows

Full size image

Cartilage destructions assessed by the Mankin scoring system

H&E and Safranin O/ Fast green staining of the articular cartilages of femoral condyles on the right side were performed via the Mankin scoring system. Well-organized articular chondrocytes with uniform nuclei and chromatin were observed in the control group. However, clumped clustering of articular chondrocytes with a disordered arrangement, pyknosis and presence of cartilaginous frailties indicated severe KOA in the model group. The surface layer of the cartilage in the SH group exhibited a concave morphology or small cracks, while the chondrocytes appeared to be disorganized. Injections of PRP into knees protected against KOA-induced articular cartilage injuries, as shown by a relative smooth surface of the cartilage, although chondrocytes were disorganized and minor fissures extended into the cartilage layer. A smooth surface of chondrocytes in arrangement was observed in the UCB-MNC group (Fig. 5A). Consistently, the Mankin score was significantly higher in the model group than in the control group, and dropped in the SH group, PRP group, and especially the UCB-MNC group (Fig. 5B, C).

Fig. 5
figure 5

A Representative images of H&E staining and Safranin O/fast green staining for articular cartilages; B Mankin score of H&E; C Mankin score of safranin O/fast green, n = 3. #P < 0.05 and ##P < 0.01 vs. UCB-MNC group; *P < 0.05 and **P < 0.01 vs. model group

Full size image

Inflammatory response in KOA rabbits

IL-1β and TNF-α levels in synovial fluid of knees were measured by ELISA. They were significantly higher in the model group than in the control group (P < 0.01). IL-1β and TNF-α levels were significantly lower in the SH group, PRP group and UCB-MNC group than in the model group, and the most pronounced reduction was detected in the UCB-MCN group (P < 0.01, Fig. 6). It is suggested that injections of UCB-MNCs into knees effectively inhibited local inflammatory response in KOA rabbits.

Fig. 6
figure 6

Relative levels of IL-1β (A) and TNF-α (B) in the synovial fluid of knees in the control group, model group, SH group, PRP group and UCB-MNC group. n = 10. #P < 0.05 and ##P < 0.01 vs. UCB-MNC group; *P < 0.05 and **P < 0.01 vs. model group

Full size image

mRNA levels of MMP-13 and COL-II in rabbit cartilages

Compared with those in the control group, the mRNA level of MMP13 was significantly upregulated and that of COL-II downregulated in the cartilage tissues of the model group. Injections of SH, PRP and UCB-MNCs into knees all significantly downregulated MMP13 and upregulated COL-II in cartilage tissues, especially in the latter group (Fig. 7).

Fig. 7
figure 7

mRNA levels of MMP-13 (A) and COL-II (B) in cartilage tissues in the control group, model group, SH group, PRP group and UCB-MNC group. n = 6. #P < 0.05 and ##P < 0.01 vs. UCB-MNC group; *P < 0.05 and **P < 0.01 vs. model group

Full size image

Protein levels of MMP-13, COL-II, and activation of PI3K/AKT signal pathway in rabbit cartilage

Similarly, the protein level of MMP13 was significantly downregulated in the PRP group and UCB-MNC group, while that of COL-II was upregulated in the UCB-MNC group. Interestingly, p-PI3K and p-AKT were significantly upregulated in the UCB-MNC group, suggesting the involvement of thePI3K/AKT signaling pathway (Fig. 8).

Fig. 8
figure 8

Protein levels of MMP-13, COL-II, p-PI3K and p-AKT protein (A), and their quantitative analyses (B). #P < 0.05 and ##P < 0.01 vs. UCB-MNC group; *P < 0.05 and **P < 0.01 vs. model group

Full size image

Discussion

Progressive degeneration of articular cartilages is a pathological benchmark of OA [19]. Articular cartilage is a special type of connective tissue consisting of chondrocytes and extracellular matrix (ECM). Type II collagen is the main structural protein responsible for the formation of ECM network alongside aggregated proteoglycans [20, 21]. Generally, ECM metabolism has a low pace and is regulated by chondrocytes. Cartilage catabolism and anabolism are mainly maintained by matrix metalloproteinases (MMPs) and endogenous tissue inhibitors of metalloproteinases (TIMPs). Matrix metalloproteinase 13 (MMP-13), the key MMP factor, destructs articular cartilage in OA by degrading COL-II [22,23,24]. Under normal circumstances, a dynamic balance exists between catabolism and anabolism of articular cartilage. Pathological stimuli, nevertheless, trigger inflammatory response of macrophages by the phagocytosis of fragmented chondrocytes. As a result, type A synoviocytes, which are phagocytic and resemble macrophages, become inflamed to release inflammatory factors and MMPs, thus accelerating the decomposition of chondrocytes and the progression of OA [25,26,27]. Therefore, inflammatory response and degradation of COL-II can be suppressed to protect KOA.

ACLT is a widely accepted procedure to mimic KOA [28]. Joint pain, the primary symptom of KOA, seriously limits the range of motion and normal gaits [29]. Therefore, we graded the Lequesne MG behavioral score in rabbits via assessing the local pain, range of motion, joint swelling and gait changes. The lowest score was observed in the UCB-MNC group, suggesting that injections of UCB-MNCs into knees effectively alleviated the impairment on the functional behaviors in KOA rabbits. KOA is traditionally diagnosed by radiographs, and subchondral osteosclerosis and osteophyte formation are considered as early markers of KOA on CT scans [30]. It is reported that injection of mesenchymal stem cells (MSCs) into knees exerts an analgesic property, and its combination with graphene oxide effectively repairs bone defects, as manifested on CT scans in KOA rabbits [31]. In the present study, micro-CT scanning clearly visualized a significant amelioration in joint stenosis and osteophyte formation in KOA rabbits intervened by UCB-MNCs. Pathologically, well-arranged articular chondrocytes in neat layers are gradually damaged by KOA as the disease progresses [32]. The Mankin scoring system is frequently applied to assess cartilage structure, cellularity, Safranin O staining and tidemark integrity in KOA [33]. Our data revealed the lowest Mankin score in the UCB-MNC group, suggesting that injections of UCB-MNCs into knees effectively alleviated histological changes in KOA rabbits. Growing evidence has supported the essential roles of pro-inflammatory factors and pro-inflammatory signaling pathways in the pathophysiology of OA [34]. IL-1β and TNF-α are two major pro-inflammatory factor involved in the progression of OA in vivo and in vitro [35, 36]. Bone marrow mesenchymal stem cells are reported to reduce local inflammation in the KOA rabbit model through decreasing TNF-α and IL-1β levels in the joint fluid [37]. We consistently examined the elevations of TNF-α and IL-1β levels in synovial fluid of the knee in the model group, and their relative levels were most pronouncedly reduced in UCB-MNC group. Cartilage matrix plays a role in supporting, protecting and nourishing chondrocytes, among which natural collagen fibers can maintain the stability of tissue structures. MMPs are activated after KOA-induced cartilage injuries and distort the structure of the cartilage matrix by degrading type II collagen fibers. Eventually, the cartilage thins, ruptures, or even completely crumbles [38]. Bone marrow mesenchymal stem cell therapy for osteoarthritis yields an effective outcome by downregulating MMP-13 and upregulating COL-II in articular cartilages [39]. Our data also showed that injections of UCB-MNCs into knees significantly downregulated MMP-13 and upregulated COL-II, thus exerting the protective effect on articular cartilages of KOA rabbits.

The PI3K/AKT signaling pathway is well known for its regulatory effect on cartilage degradation by mediating homeostatic and cellular activities [40, 41]. Lu et al. have reported that the activated PI3K/AKT signaling pathway attenuates chondrocyte damage in OA via inhibiting the secretion of MMP13 [42]. Upregulations of p-PI3K and p-AKT were more prominent in the UCB-MNC group than in the model group, suggestive of the activation of the PI3K/AKT signaling pathway in protecting KOA.

There were some limitations in our study. First, we did not profile the safety of knee injections of UCB-MNCs in the treatment of KOA. Second, downstream targets of the PI3K/AKT signaling pathway that are responsible for the therapeutic effect of UCB-MNCs should be further examined. Third, the clinical application of UCB-MNCs to KOA requires further explorations in clinical trials.

Conclusion

Injections of UCB-MNCs into knees protect the articular cartilage and inhibited the progression of KOA in rabbits by optimizing the local microenvironment at knee joints.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Quinn R H, Murray J, Pezold R, et al. The American academy of orthopaedic surgeons appropriate use criteria for surgical management of osteoarthritis of the knee [J]. J Bone Joint Surg Am. 2017;99(8):697–9.

    Article  PubMed  Google Scholar 

  2. Abbasi J. Can exercise prevent knee osteoarthritis? [J]. JAMA. 2017;318(22):2169–71.

  3. Zhang W, Dass C Ouyangh. Current research on pharmacologic and regenerative therapies for osteoarthritis [J]. Bone Res. 2016;4:15040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tanaka E, Detamore M S Mercurilg. Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment [J]. J Dent Res. 2008;87(4):296–307.

    Article  PubMed  Google Scholar 

  5. Liu L, Li Y. Chondroprotective and anti-nociceptive effects of caffeoylquinic acid in osteoarthritis by downregulating catabolic activity and oxidative damage in chondrocytes [J]. Biomed Pharmacother. 2017;93:985–94.

    Article  CAS  PubMed  Google Scholar 

  6. Bruschettini M, Romantsik O. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants [J]. Cochrane Database Syst Rev. 2020;8(8):CD013202.

    PubMed  Google Scholar 

  7. Peng X, Song J, Li B, et al. Umbilical cord blood stem cell therapy in premature brain injury: opportunities and challenges [J]. J Neurosci Res. 2020;98(5):815–25.

    Article  CAS  PubMed  Google Scholar 

  8. Weiss ML, Anderson C. Immune properties of human umbilical cord Wharton’s jelly-derived cells [J]. Stem Cells. 2008;26(11):2865–74.

    Article  CAS  PubMed  Google Scholar 

  9. Troyer DL, Weiss ML. Wharton’s jelly-derived cells are a primitive stromal cell population [J]. Stem Cells. 2008;26(3):591–9.

    Article  Google Scholar 

  10. Rallapalli S, Guhathakurta S, Narayan S, et al. Generation of clinical-grade red blood cells from human umbilical cord blood mononuclear cells [J]. Cell Tissue Res. 2019;375(2):437–49.

    Article  CAS  PubMed  Google Scholar 

  11. Kim JE, Lee SM, Kim SH, et al. Effect of self-assembled peptide-mesenchymal stem cell complex on the progression of osteoarthritis in a rat model [J]. Int J Nanomed. 2014;9(Suppl 1Suppl 1):141–57.

    Article  Google Scholar 

  12. Chiang ER, Ma H L, Wang JP, et al. Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits [J]. PLoS ONE. 2016;11(2):e0149835.

    Article  Google Scholar 

  13. Li XW, Feng LX, Zhu XJ, et al. Human umbilical cord blood mononuclear cells protect against renal tubulointerstitial fibrosis in cisplatin-treated rats [J]. Biomed Pharmacother. 2020;121:109662.

    Article  PubMed  Google Scholar 

  14. Paton MCB, Allison BJ, Fahey MC, et al. Umbilical cord blood versus mesenchymal stem cells for inflammation-induced preterm brain injury in fetal sheep [J]. Pediatr Res. 2019;86(2):165–73.

    Article  PubMed  Google Scholar 

  15. Fang C, Guo JW, Wang YJ, et al. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion [J]. Acta Pharmacol Sin. 2022;43(5):1299–310.

    Article  CAS  PubMed  Google Scholar 

  16. Hermeto LC, Rossi R, Jardim PR. Comparison between two different experimental models of osteoarthritis in rabbits. Intra-articular collagenase injection and anterior cruciate ligament transection [J]. Acta Cir Bras. 2016;31(9):602–7.

    Article  PubMed  Google Scholar 

  17. Lequesne MG, Samson M. Indices of severity in osteoarthritis for weight bearing joints [J]. J Rheumatol Suppl. 1991;27:16–8.

    PubMed  Google Scholar 

  18. van der Sluijs JA, Geesink RG, van der Linden AJ, et al. The reliability of the Mankin score for osteoarthritis [J]. J Orthop Res. 1992;10(1):58–61.

    Article  PubMed  Google Scholar 

  19. Choi M C, Jo J, Park J et al. NF-kappaB signaling pathways in osteoarthritic cartilage destruction [J]. Cells. 2019;8(7).

  20. Poole AR, Kobayashi M, Yasuda T, et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis [J]. Ann Rheum Dis. 2002;61(Suppl 2):ii78–81.

    Article  PubMed  Google Scholar 

  21. Huang K, Wu LD. Aggrecanase and aggrecan degradation in osteoarthritis: a review [J]. J Int Med Res. 2008;36(6):1149–60.

    Article  CAS  PubMed  Google Scholar 

  22. Man GS. Osteoarthritis pathogenesis - a complex process that involves the entire joint [J]. J Med Life. 2014;7(1):37–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang FJ, Yu WB, Luo W, et al. Effect of osteopontin on TIMP-1 and TIMP-2 mRNA in chondrocytes of human knee osteoarthritis in vitro [J]. Exp Ther Med. 2014;8(2):391–4.

    Article  PubMed  Google Scholar 

  24. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage [J]. J Clin Invest. 1996;97(3):761–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mueller MB, Tuan RS. Anabolic/catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets [J]. PM R. 2011;3(6 Suppl 1):S3–11.

    PubMed  Google Scholar 

  26. Di Rosa M, Castrogiovanni P. Musumeci G. The synovium theory: can exercise prevent knee osteoarthritis? The role of mechanokines, a possible biological key [J]. J Funct Morphol Kinesiol. 2019;4(1).

  27. Castrogiovanni P, Di Rosa M Ravallis et al. Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key [J]. Int J Mol Sci. 2019;20(3).

  28. Yoshioka M, Coutts RD, Amiel D, et al. Characterization of a model of osteoarthritis in the rabbit knee [J]. Osteoarthritis Cartilage. 1996;4(2):87–98.

    Article  CAS  PubMed  Google Scholar 

  29. Hunter D J, Bierma-Zeinstra S. Osteoarthritis [J]. Lancet. 2019;393(10182):1745–59.

    Article  Google Scholar 

  30. Sakellariou G, Conaghan PG, Zhang W, et al. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis [J]. Ann Rheum Dis. 2017;76(9):1484–94.

    Article  PubMed  Google Scholar 

  31. Fan M, Tong P. Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis [J]. BMC Med. 2023;21(1):215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Harkey MS, Luc BA, Golightly YM, et al. Osteoarthritis-related biomarkers following anterior cruciate ligament injury and reconstruction: a systematic review [J]. Osteoarthritis Cartilage. 2015;23(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  33. Liu D, Wu YL, Li C, et al. Warming moxibustion attenuates inflammation and cartilage degradation in experimental rabbit knee osteoarthriti [J]. J Tradit Chin Med. 2021;41(6):959–67.

    PubMed  Google Scholar 

  34. Goldring MB, Otero M. Inflammation in osteoarthritis [J]. Curr Opin Rheumatol. 2011;23(5):471–8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis [J]. Nat Rev Rheumatol. 2016;12(10):580–92.

    Article  PubMed  Google Scholar 

  36. Philpott HT, O’Brien M, McDougall JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis [J]. Pain. 2017;158(12):2442–51.

    Article  PubMed  Google Scholar 

  37. Huang H, Zhang P, Xiang C, et al. Effect of bone marrow mesenchymal stem cell transplantation combined with lugua polypeptide injection on osteoarthritis in rabbit knee joint [J]. Connect Tissue Res. 2022;63(4):370–81.

    Article  CAS  PubMed  Google Scholar 

  38. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J]. J Clin Invest. 1997;99(7):1534–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Song F, Tang J, Geng R, et al. Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model [J]. Int J Clin Exp Pathol. 2014;7(4):1415–26.

    PubMed  PubMed Central  Google Scholar 

  40. Cravero JD, Carlson CS, Im HJ, et al. Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis [J]. Arthritis Rheum. 2009;60(2):492–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Litherland GJ, Dixon C, Lakey RL, et al. Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent [J]. J Biol Chem. 2008;283(21):14221–9.

    Article  CAS  PubMed  Google Scholar 

  42. Lu J, Feng X, Zhang H, et al. Maresin-1 suppresses IL-1beta-induced MMP-13 secretion by activating the PI3K/AKT pathway and inhibiting the NF-kappaB pathway in synovioblasts of an osteoarthritis rat model with treadmill exercise [J]. Connect Tissue Res. 2021;62(5):508–18.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Science Technology Foudation of Yantai City (2023YD055).

Author information

Authors and Affiliations

  1. The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264199, Shandong Province, China

    Yuhang Fu & Meng Yang

  2. Yantai Affiliated Hospital of Binzhou Medical University, Yantai, 264199, Shandong Province, China

    Yuhang Fu, Chi Zhang, Baisui Zhou, Meng Yang, Guoshuai Zhu & Yonglin Zhu

  3. Yantai City Yantai Mountain Hospital, Yantai, 264008, Shandong Province, China

    Yong Yang

Authors
  1. Yuhang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baisui Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guoshuai Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yonglin Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y.F conduct experiments and write the mian manuscriptC.Z design experiments and revise manuscriptY.Y and B.Z statistics and analysisM.Y and G.Z prepared figuresY.Z final revisions were made to the manuscriptAll authors reviewed the manuscript.

Corresponding author

Correspondence to Yonglin Zhu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, Y., Zhang, C., Yang, Y. et al. Effect of umbilical cord blood-mononuclear cells on knee osteoarthritis in rabbits. J Orthop Surg Res 19, 323 (2024). https://doi.org/10.1186/s13018-024-04815-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-024-04815-8

Keywords

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X